ResMed Inc. (RMD)
RMD trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$235.04
+0.19% on the day
Market cap
$33.1B
Large cap
Revenue · 2025
$5.1B
+9.8% on 2024
Net income · 2025
$1.4B
27.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | RMD on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000943819 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $5.1B |
| Net income | $1.4B |
| Operating income | $1.7B |
| Net margin | 27.2% |
| Operating margin | 32.7% |
| Revenue growth | +9.8% |
| Cash | $1.4B |
| Total assets | $8.5B |
| P/E (computed) | 23.6× |
| P/S (computed) | 6.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 10-K | 2026-08-13 |
| Latest quarterly / interim | 10-Q | 2026-05-01 |
| Latest current report | 8-K | 2026-09-01 |
| Latest proxy | DEFA14A | 2026-10-01 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +3.5% |
| 1 month | +2.0% |
| 3 months | +15.4% |
| Year to date | -2.9% |
| 1 year | -14.3% |
| From 52-week high | -15.2% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DXCM | DexCom Inc. | $85.06 | -1.00% | $32.1B |
| WST | West Pharmaceutical Services Inc. | $371.82 | +1.15% | $26.2B |
| MDLN | Medline Inc. | $35.70 | -0.17% | $46.9B |
| BDX | Becton Dickinson and Company | $187.37 | -0.81% | $51.0B |
| BSX | Boston Scientific Corporation | $43.31 | -1.21% | $62.8B |
| SOLV | Solventum Corporation | $86.30 | +1.16% | $14.7B |
| MMM | 3M Company | $162.77 | +1.17% | $83.9B |
| BAX | Baxter International Inc. | $24.89 | +0.44% | $12.9B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier